Cisatracurium Besylate Injection
Product Images NDC 70710-1532

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Cisatracurium Besylate (NDC 70710-1532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6441f3e5 0868 4b57 Badf D6a8ea7e8584 01)

Chemical structure diagram of cisatracurium besylate, depicting the molecular arrangement including aromatic rings, methoxy groups, and sulfonate components as indicated.*

FDA Label Image

Image (6441f3e5 0868 4b57 Badf D6a8ea7e8584 02)

A scatter plot chart showing the relationship between percentage changes in mean arterial pressure (MAP) and heart rate (HR), each axis ranging from -60% to +60%. The plot contains multiple data points clustered near the center, indicating relative stability in MAP and HR values.*

FDA Label Image

Image (6441f3e5 0868 4b57 Badf D6a8ea7e8584 03)

Scatter plot chart showing data points distributed around the origin with axes labeled for percentage change, representing variables 'HR' on the vertical axis and 'MAP' on the horizontal axis, both ranging from -60% to +60%.*

FDA Label Image

Image10 (6441f3e5 0868 4b57 Badf D6a8ea7e8584 04)

Label for cisatracurium besylate injection, USP, 10 mg/5 mL (2 mg/mL) single-dose vial. The label indicates it is a sterile, nonpyrogenic solution for intravenous injection distributed by Zydus Pharmaceuticals USA Inc. Storage instructions specify 2°C to 8°C (36°F to 46°F) and protection from light. It includes warnings for paralysis and respiratory arrest requiring artificial respiration. The label features the NDC 70710-1532-1 and notes the product is preservative-free.*

FDA Label Image

Image11 (6441f3e5 0868 4b57 Badf D6a8ea7e8584 05)

Label for Cisatracurium Besylate Injection, USP 10 mg/mL (200 mg/20 mL) by Zydus Pharmaceuticals USA Inc. This intravenous injection is a 20 mL single-dose vial and preservative-free. The label includes storage instructions at 2°C to 8°C, a warning that it is a paralyzing agent requiring ICU use only, and information about dosage and product origin (Made in India).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.